Company Filing History:
Years Active: 2014-2016
Title: Dana Ungermannova: Innovator in Macrocyclic Compounds
Introduction
Dana Ungermannova is a notable inventor based in the United States. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of macrocyclic compounds. Her work focuses on creating innovative solutions for treating diseases through the inhibition of histone deacetylases.
Latest Patents
Dana Ungermannova holds a patent for her invention titled "Macrocyclic Compounds Useful As Inhibitors Of Histone Deacetylases." This invention provides a novel macrocyclic compound of general Formula (I) that exhibits histone deacetylase (HDAC) inhibitory activity. The patent also includes a pharmaceutical composition comprising the compound and outlines a method for treating diseases using this compound.
Career Highlights
Throughout her career, Dana has demonstrated a commitment to advancing medical science through her research and innovations. Although she currently holds no patents, her work in the field has laid the groundwork for future developments in HDAC inhibitors.
Collaborations
Dana has collaborated with esteemed colleagues, including Xuedong Liu and Andrew J Phillips. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative projects.
Conclusion
Dana Ungermannova is a pioneering inventor whose work in macrocyclic compounds has the potential to impact the treatment of various diseases. Her contributions to pharmaceutical chemistry highlight the importance of innovation in medical research.